These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 36934619)
1. Characterization and exploration of an artifact in the reducing capillary electrophoresis-sodium dodecyl sulfate analysis of the 'me-too' drug zuberitamab related to rituximab. Gao H; Wang ST; Wang H; Fang WJ J Pharm Biomed Anal; 2023 May; 228():115347. PubMed ID: 36934619 [TBL] [Abstract][Full Text] [Related]
2. Investigation of an Uncommon Artifact during Reducing Capillary Electrophoresis-Sodium Dodecyl Sulfate Analysis of a Monoclonal Antibody with Dynamic Light Scattering and Reversed Phase High-Performance Liquid Chromatography. Gao H; Wang ST; Hu F; Shen BB; Sun MF; Wang H; Li L; Fang WJ Pharm Res; 2022 Aug; 39(8):1959-1968. PubMed ID: 35701679 [TBL] [Abstract][Full Text] [Related]
3. Using capillary electrophoresis sodium dodecyl sulfate (CE-SDS) and liquid chromatograph mass spectrometry (LC-MS) to identify glycosylated heavy chain heterogeneity in the anti-VEGFR-2 monoclonal antibody. Li M; Zhao X; Wu G; Wang W; Du J; Xu G; Duan M; Fu Z; Yu C; Wang L Electrophoresis; 2024 Aug; 45(15-16):1281-1294. PubMed ID: 38361212 [TBL] [Abstract][Full Text] [Related]
4. Elimination of light chain tailing in reducing capillary electrophoresis with sodium dodecyl sulfate analysis of a monoclonal antibody. Wang ST; Gao H; Shen BB; Wang H; Fang WJ Electrophoresis; 2022 Oct; 43(18-19):1850-1858. PubMed ID: 35776503 [TBL] [Abstract][Full Text] [Related]
5. Characterization workflow for fragments detected in capillary electrophoresis sodium dodecyl sulfate analysis of therapeutic monoclonal antibodies. Fei M; Zhang Q; Zhang L; Zhang Y; Wang L; Zhao Y; Zhang Z Electrophoresis; 2024 Aug; 45(15-16):1325-1338. PubMed ID: 38458992 [TBL] [Abstract][Full Text] [Related]
6. Characterization and elimination of artificial non-covalent light Chain dimers in reduced CE-SDS analysis of pertuzumab. Zhang L; Fei M; Tian Y; Li S; Zhu X; Wang L; Xu Y; Xie MH J Pharm Biomed Anal; 2020 Oct; 190():113527. PubMed ID: 32911382 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods. Li W; Yang B; Zhou D; Xu J; Li W; Suen WC J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491 [TBL] [Abstract][Full Text] [Related]
8. Minimization of artifact protein aggregation using tetradecyl sulfate and hexadecyl sulfate in capillary gel electrophoresis under reducing conditions. Guan Q; Atsma J; Tulsan R; Voronov S; Ding J; Beckman J; Li ZJ Electrophoresis; 2020 Jul; 41(13-14):1245-1252. PubMed ID: 32297333 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic protein purity and fragmented species characterization by capillary electrophoresis sodium dodecyl sulfate using systematic hybrid cleavage and forced degradation. Duhamel L; Gu Y; Barnett G; Tao Y; Voronov S; Ding J; Mussa N; Li ZJ Anal Bioanal Chem; 2019 Aug; 411(21):5617-5629. PubMed ID: 31214752 [TBL] [Abstract][Full Text] [Related]
10. Interlaboratory method validation of capillary electrophoresis sodium dodecyl sulfate (CE-SDS) methodology for analysis of mAbs. Li M; Yu C; Wang W; Wu G; Wang L Electrophoresis; 2021 Oct; 42(19):1900-1913. PubMed ID: 34240427 [TBL] [Abstract][Full Text] [Related]
11. Implementation of USP antibody standard for system suitability in capillary electrophoresis sodium dodecyl sulfate (CE-SDS) for release and stability methods. Esterman AL; Katiyar A; Krishnamurthy G J Pharm Biomed Anal; 2016 Sep; 128():447-454. PubMed ID: 27344634 [TBL] [Abstract][Full Text] [Related]
12. Using differential scanning calorimetry for the development of non-reduced capillary electrophoresis sodium dodecyl sulfate methods for monoclonal antibodies. Molina P; Schick AJ; Welch L; Niedringhaus T; Hierro GD; Deperalta G; Hieb A Anal Biochem; 2020 Nov; 609():113948. PubMed ID: 32919940 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of low-molecular-weight protein aggregation by CE-SDS as a complementary method to SE-HPLC. Wang ST; Sun MF; Gao H; Shen BB; Fang WJ J Pharm Biomed Anal; 2023 Sep; 234():115521. PubMed ID: 37327620 [TBL] [Abstract][Full Text] [Related]
14. Specific and high-resolution identification of monoclonal antibody fragments detected by capillary electrophoresis-sodium dodecyl sulfate using reversed-phase HPLC with top-down mass spectrometry analysis. Wang WH; Cheung-Lau J; Chen Y; Lewis M; Tang QM MAbs; 2019 Oct; 11(7):1233-1244. PubMed ID: 31348730 [TBL] [Abstract][Full Text] [Related]
15. Identification of a monoclonal antibody clipping variant by cross-validation using capillary electrophoresis - sodium dodecyl sulfate, capillary zone electrophoresis - mass spectrometry and capillary isoelectric focusing - mass spectrometry. Li M; Zhao X; Shen D; Wu G; Wang W; Yu C; Sausen J; Xu H; Wang L J Chromatogr A; 2022 Nov; 1684():463560. PubMed ID: 36288623 [TBL] [Abstract][Full Text] [Related]
16. Sodium dodecyl sulfate-capillary gel electrophoresis with native fluorescence detection for analysis of therapeutic proteins. Zhu Z; Lies M; Silzel J J Pharm Biomed Anal; 2022 May; 213():114689. PubMed ID: 35240406 [TBL] [Abstract][Full Text] [Related]
17. Identification of a CE-SDS shoulder peak as disulfide-linked fragments from common C Cao M; Jiao Y; Parthemore C; Korman S; Ma J; Hunter A; Kilby G; Chen X MAbs; 2021; 13(1):1981806. PubMed ID: 34719342 [TBL] [Abstract][Full Text] [Related]
18. Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies. Salas-Solano O; Tomlinson B; Du S; Parker M; Strahan A; Ma S Anal Chem; 2006 Sep; 78(18):6583-94. PubMed ID: 16970337 [TBL] [Abstract][Full Text] [Related]
19. Online top-down mass spectrometric identification of CE(SDS)-separated antibody fragments by two-dimensional capillary electrophoresis. Römer J; Stolz A; Kiessig S; Moritz B; Neusüß C J Pharm Biomed Anal; 2021 Jul; 201():114089. PubMed ID: 33940498 [TBL] [Abstract][Full Text] [Related]
20. Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities. Wagner E; Colas O; Chenu S; Goyon A; Murisier A; Cianferani S; François Y; Fekete S; Guillarme D; D'Atri V; Beck A J Pharm Biomed Anal; 2020 May; 184():113166. PubMed ID: 32113118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]